Literature DB >> 19247594

[Non-surgical treatment of osteoarthritis of large joints - new aspects].

Ernst Wagner1.   

Abstract

A large number of treatment options exist for osteoarthritis of the knee and hip. The choice of therapy depends on clinical symptomatology, preexisting risk factors (e.g. obesity), and disease stage. This review includes the novel aspects of symptomatic conservative treatment (physical medicine and drugs), especially pain management (electrotherapy), and rehabilitational aspects. Rehabilitation is essential, as osteoarthritis is a chronic condition, that requires lifelong intervention, and a causal cure has not been identified yet. New aspects of hyaluronic acid, slow-acting symptomatic drugs in osteoarthritis (chondroitin sulfate, glucosamine sulfate, and diacerein), and experimental drugs, which claim the properties of disease modification in osteoarthritis (bisphosphonates, calcitonin, and interleukin-1 antagonists), are discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19247594     DOI: 10.1007/s10354-008-0603-2

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  63 in total

1.  Total hip replacement due to osteoarthritis: the importance of age, obesity, and other modifiable risk factors.

Authors:  Elizabeth W Karlson; Lisa A Mandl; Gideon N Aweh; Oliver Sangha; Matthew H Liang; Francine Grodstein
Journal:  Am J Med       Date:  2003-02-01       Impact factor: 4.965

Review 2.  Strategies for the prevention and management of osteoarthritis of the hip and knee.

Authors:  J W J Bijlsma; K Knahr
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-02       Impact factor: 4.098

3.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

4.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

5.  Risk factors for the incidence and progression of radiographic knee osteoarthritis.

Authors:  C Cooper; S Snow; T E McAlindon; S Kellingray; B Stuart; D Coggon; P A Dieppe
Journal:  Arthritis Rheum       Date:  2000-05

Review 6.  Exercise therapy for treatment of non-specific low back pain.

Authors:  J A Hayden; M W van Tulder; A Malmivaara; B W Koes
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

Review 7.  What is the evidence for viscosupplementation in the treatment of patients with hip osteoarthritis? Systematic review of the literature.

Authors:  Michel P J van den Bekerom; Bas Lamme; An Sermon; Michiel Mulier
Journal:  Arch Orthop Trauma Surg       Date:  2007-09-15       Impact factor: 3.067

8.  Effects of calcitonin on subchondral trabecular bone changes and on osteoarthritic cartilage lesions after acute anterior cruciate ligament deficiency.

Authors:  Catherine Behets; James M Williams; Daniel Chappard; Jean-Pierre Devogelaer; Daniel-Henri Manicourt
Journal:  J Bone Miner Res       Date:  2004-06-28       Impact factor: 6.741

9.  Relationship of height, weight and body mass index to the risk of hip and knee replacements in middle-aged women.

Authors:  B Liu; A Balkwill; E Banks; C Cooper; J Green; V Beral
Journal:  Rheumatology (Oxford)       Date:  2007-02-04       Impact factor: 7.580

10.  The efficacy, safety and carry-over effect of diacerein in the treatment of painful knee osteoarthritis: a randomised, double-blind, NSAID-controlled study.

Authors:  W Louthrenoo; S Nilganuwong; S Aksaranugraha; P Asavatanabodee; S Saengnipanthkul
Journal:  Osteoarthritis Cartilage       Date:  2007-04-19       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.